Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03646123
Title Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | POL | ITA | ESP | CZE | AUS


No variant requirements are available.